Questions I guess the question is: is it better to sell AH for 100plus or human for 200?? The upside for AH is years sooner than human. Significant commercialization is probably a year away for Canada and Commonwealth and 4 years away for rest of the world. Is it a home run then? probably. Is it still a gamble? absolutely. When I bought this stock I always thought FDA would be finished end of 2013 approval some time in 2014. Now that is 2017?? That is a long at away for an old man like me.
Is AH scalable as GW and most of us think. Can we have the best of both worlds with Another route? Lots of questions. If I were a betting man, and obviously I am, I would guess no matter what happens, the starting point will be substantially higher with GW running the show. Although a new CEO with some street cred with therapeutics will help as well. So many questions so few answers... for now. It will get interesting that's for sure.
Beech